203
Participants
Start Date
January 31, 2011
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2012
Research Site, Beijing
Research Site, Fuzhou
Research Site, Xiamen
Research Site, Zhangzhou
Research Site, Guangzhou
Research Site, Xingtai
Research Site, Haerbing
Research Site, Zhenzhou
Research Site, Wuhan
Research Site, Changzhou
Research Site, Nanjing
Research Site, Nantong
Research Site, Suzhou
Research Site, Dalian
Research Site, Shanghai
Research Site, Chengdu
Research Site, Tianjin
Research Site, Kunming
Lead Sponsor
AstraZeneca
INDUSTRY